Pasadena, Calif.-based Terray Therapeutics, which combines nanotechnology with artificial intelligence, has raised $60 million in a Series A funding round led by Seattle’s Madrona Venture Group. Terray’s chips are fit with millions of molecules that can be used for drug-target screening, with...
Terray Therapeutics
Auto Added by WPeMatico
Pasadena, Calif.-based Terray Therapeutics, which combines nanotechnology with artificial intelligence, has raised $60 million in a Series A funding round led by Seattle’s Madrona Venture Group. Terray’s chips are fit with millions of molecules that can be used for drug-target screening, with...
Pasadena, Calif.-based Terray Therapeutics, which combines nanotechnology with artificial intelligence, has raised $60 million in a Series A funding round led by Seattle’s Madrona Venture Group. Terray’s chips are fit with millions of molecules that can be used for drug-target screening, with...
Pasadena, Calif.-based Terray Therapeutics, which combines nanotechnology with artificial intelligence, has raised $60 million in a Series A funding round led by Seattle’s Madrona Venture Group. Terray’s chips are fit with millions of molecules that can be used for drug-target screening, with...
Pasadena, Calif.-based Terray Therapeutics, which combines nanotechnology with artificial intelligence, has raised $60 million in a Series A funding round led by Seattle’s Madrona Venture Group. Terray’s chips are fit with millions of molecules that can be used for drug-target screening, with...
Pasadena, Calif.-based Terray Therapeutics, which combines nanotechnology with artificial intelligence, has raised $60 million in a Series A funding round led by Seattle’s Madrona Venture Group. Terray’s chips are fit with millions of molecules that can be used for drug-target screening, with...